Centers & Services

Top > Centers & Services > Central Clinical Facilities and Clinical Research Division > Department of Blood Transfusion

Department of Blood Transfusion

With a focus on safe and appropriate transfusion therapy, the department tests, controls, and supplies allogeneic blood for transfusion, and collects, controls and supplies autologous blood for elective surgery patients. The department also collects, preserves, and supplies cell vaccines for cancer immunotherapy and hematopoietic stem cells for transplantation in leukemia patients.

Medical services

With the utmost emphasis on safety, transfusion therapy is performed by 6 medical doctors (transfusionists), 10 laboratory technologists, and 2-3 nurses. Provision of advice and instruction on transfusion therapy, control, testing, and supply of blood for transfusion, consultation and blood collection of patients appointed for autologous blood transfusion, collection, culture and administration of cell vaccines for cancer immunotherapy, and collection, preservation and supply of peripheral blood stem cells for transplantation are the main clinical activities of the department.

Treatment policy

The transfusionists provide advice and instructions, when required, for the policymaking of transfusion therapy of each department. The policymaking of transfusion therapy of the hospital is established through discussions at the Hospital Transfusion Committee. The treatment plan for patients receiving cancer immunotherapy and hematopoietic stem cell collection is determined jointly with doctors of the department in charge.

Specialties

  • Autologous blood transfusion is indicated to elective surgery patients in good general condition. The transfusionist consults the patient, provides information, obtains the specific informed consent, and makes the collection plan. Under careful observation of the patient’s condition, the transfusionist and the nurse perform the safe blood collection, aiming avoidance of allogeneic blood.
  • Cancer immunotherapy is performed as a highly-advanced medical treatment option in patients with various solid cancers.
  • Hematopoietic stem cell transplantation: peripheral blood stem cells are collected for transplantation.
Hitoshi Okazaki

Hitoshi Okazaki

Departments/Divisions

Department of Blood Transfusion

Titles

M.D., Ph.D.

Expertise/Specialties

Transfusion Medicine, Respiratory Medicine, Allergy and Clinical Immunology

Research Interests

Mechanism of transfusion complications, Haemovigilance

Languages

Japanese / English

See More

page top